NM_002439.5:c.-5C>G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002439.5(MSH3):c.-5C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000208 in 1,443,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002439.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081 | c.-5C>G | 5_prime_UTR_variant | Exon 1 of 24 | 1 | NM_002439.5 | ENSP00000265081.6 | |||
DHFR | ENST00000439211.7 | c.-234G>C | 5_prime_UTR_variant | Exon 1 of 6 | 1 | NM_000791.4 | ENSP00000396308.2 | |||
MSH3 | ENST00000667069 | c.-5C>G | 5_prime_UTR_variant | Exon 1 of 22 | ENSP00000499502.1 | |||||
MSH3 | ENST00000670357.1 | n.-5C>G | non_coding_transcript_exon_variant | Exon 1 of 25 | ENSP00000499791.1 | |||||
MSH3 | ENST00000670357.1 | n.-5C>G | 5_prime_UTR_variant | Exon 1 of 25 | ENSP00000499791.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000441 AC: 1AN: 226922Hom.: 0 AF XY: 0.00000799 AC XY: 1AN XY: 125116
GnomAD4 exome AF: 0.00000208 AC: 3AN: 1443992Hom.: 0 Cov.: 35 AF XY: 0.00000139 AC XY: 1AN XY: 718812
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The c.-5C>G variant is located in the 5' untranslated region (5’ UTR) of the MSH3 gene. This variant results from a C to G substitution 5 bases upstream from the first translated codon. This nucleotide position is not well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at